These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 6860085)

  • 1. [Carminomycin in combination with some cytostatics. 1. Efficacy in leukemia L1210].
    Nowak C; Arnold W; Henneberger G; Tanneberger S
    Arch Geschwulstforsch; 1983; 53(1):45-52. PubMed ID: 6860085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapeutic effectiveness of carminomycin (CRM) in combination with dibromodulcitol (DBD) compared with the combination vincristine, cyclophosphamide, methotrexate, 5-fluorouracil (VCMF) on some tumor systems (author's transl)].
    Nowak C; Arnold W; Henneberger G; Tanneberger S
    Arch Geschwulstforsch; 1980; 50(8):747-57. PubMed ID: 7224818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Action of carminomycin on leukemic cell proliferation and some problems of its use in the combined therapy of leukemias].
    Egorov LV; Khanykova OK; Kuznetsova TV; Rudneva NA; Kozinets GI
    Antibiotiki; 1978 Sep; 23(9):833-6. PubMed ID: 697341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antileukemic activity of carminomycin complexes with a high-polymer DNA].
    Vaĭnberg IuP; Egorov LV; Kuznetsova TV; Rudneva NA; Khanykova OK
    Antibiotiki; 1980 Jun; 25(6):454-8. PubMed ID: 7396445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic performance of carminomycin-cyclophosphamide against L1210 leukemia.
    Avery TL; Cruze PG
    Cancer Res; 1978 Sep; 38(9):2892-5. PubMed ID: 679196
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative characteristics of the antitumor and immunodepressive activity of carminomycin on the L-1210 experimental model].
    Berezina TA; Uteshev BS
    Antibiotiki; 1979 Oct; 24(10):767-71. PubMed ID: 496420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative experimental study of the antileukemia activity of carminomycin and rubomycin].
    Khanykova OK; Vinogorova GF
    Antibiotiki; 1977 Sep; 22(9):846-52. PubMed ID: 911158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effectivity of carminomycin in combination with dibromodulcitol on human tumor cells in vitro (author's transl)].
    Projan A; Nissen E; Tanneberger S
    Arch Geschwulstforsch; 1981; 51(6):497-502. PubMed ID: 7332443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Carminomycin in the therapy of leukemias].
    Vygovskaia IaI; Mazurok AA; Kondrat'eva NA; Orel VG
    Antibiotiki; 1982 Aug; 27(8):632-5. PubMed ID: 6957161
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of carminomycin in combination with UHF hyperthermia in the therapy of sarcoma 180].
    Lopatin VF; Dedenkov AN; Vatin AE
    Antibiotiki; 1979 Aug; 24(8):619-22. PubMed ID: 485112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of a mixture of carminomycin and cyanoacrylates on experimental tumor growth].
    Chissov VI; Rusakov IG; Akimova AIa; Shchitkov KG
    Vopr Onkol; 1982; 28(6):41-5. PubMed ID: 7090296
    [No Abstract]   [Full Text] [Related]  

  • 12. Combined therapy of L1210 leukemia with Damvar and cytostatics.
    Pujman V; Cernochová S
    Neoplasma; 1979; 26(5):521-3. PubMed ID: 522924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular pharmacological differences between carminomycin and its analog, carminomycin-11-methyl ether, and adriamycin.
    DuVernay VH; Pachter JA; Crooke ST
    Cancer Res; 1980 Feb; 40(2):387-94. PubMed ID: 7356521
    [No Abstract]   [Full Text] [Related]  

  • 14. [Synthesis, toxicity and antitumor action of carminomycin azine (carminazine)].
    Povarov LS; Gol'dberg LE; Bazhanov VS; Shepelevtseva NG; Vertogradova TP
    Antibiotiki; 1981 Aug; 26(8):620-3. PubMed ID: 6895293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic effect of ricin in combination with daunorubicin, cis-dichlorodiammineplatinum(II) and vincristine in systemic L1210 leukemia.
    Fodstad O; Pihl A
    Cancer Res; 1982 Jun; 42(6):2152-8. PubMed ID: 7200398
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antitumor activity and the effect on immunogenesis of combinations of rubomycin and carminomycin with levamisole].
    Vatin AE; Filatov PP
    Antibiotiki; 1982 Apr; 27(4):284-7. PubMed ID: 6896414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Action of carminomycin on the kinetics of cell proliferation and some problems of its combined use with other cytostatic agents].
    Egorov LV; Khanykova OK; Kuznetsova TV; Gerasimova NA; Kozinets GI
    Antibiotiki; 1977 Jul; 22(7):639-43. PubMed ID: 883808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Synthesis and study of the antitumor properties of 13-hydrazone-substituted carminomycin].
    Povarov LS; Olsuf'eva EN; Bazhanov VS; Filippos'iants ST; Shepelevtseva NG
    Antibiotiki; 1982 Feb; 27(2):137-40. PubMed ID: 6895983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new anthracycline metabolite D788-1 (10-carboxy-13-deoxocarminomycin) in daunorubicin beer.
    Fujii S; Kubo K; Johdo O; Yoshimoto A; Ishikura T; Naganawa H; Sawa T; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1986 Mar; 39(3):473-5. PubMed ID: 3700249
    [No Abstract]   [Full Text] [Related]  

  • 20. [Intensification of the cytostatic action of adriamycin and carminomycin by amphotericin B].
    Makukho LV; Volkolupova OP; Gauze GF
    Antibiotiki; 1980 Apr; 25(4):294-6. PubMed ID: 7369735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.